REZI Q1 2026 Earnings Strong EPS Beat Amidst Mixed Market Reaction MHK Q1 2026 Earnings EPS Beats Estimates Amidst Challenging Markets TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress Live Oak Bancshares LOB Q1 2026 Earnings Strong EPS Beat as Net Interest Margins Hold Steady Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline RKLB Q1 2026 Earnings EPS Beat Driven by Strong Space Systems Execution